Longduoduo Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LDDD research report →
Price Chart
About the company
Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives.
- CEO
- Hongxiao Zhou
- IPO
- 2023
- Employees
- 52
- HQ
- Hohhot, MO, CN
Get TickerSpark's AI analysis on LDDD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.31M
- P/E
- -26.56
- PEG
- 0.23
- P/S
- 8.40
- P/B
- 21.75
- EV/EBITDA
- -29.31
- Div Yield
- 0.00%
- Gross Margin
- 97.52%
- Op Margin
- -34.74%
- Net Margin
- -31.75%
- ROE
- -67.52%
- ROIC
- -78.67%
Latest fiscal year · YoY change
- Revenue
- $1.82M-57.2%
- Gross Profit
- $1.81M-56.7%
- Op Income
- $-633,181
- Net Income
- $-578,631-225.7%
- EPS
- $-0.02-226.1%
- OCF Growth
- -158.8%
- FCF Growth
- -188.9%
- 52W High
- $1.10
- 52W Low
- $0.51
- 50D MA
- $0.51
- 200D MA
- $0.53
- Beta
- 1.19
- RSI (14)
- 0
- Avg Volume
- 249
No earnings-call transcripts are available for LDDD yet.
- Free Float
- 32.3%
- Shares Outstanding
- 30.02M
- Float Shares
- 9.71M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 25, 24 | Ma Jiayang | other | 0 |
| Nov 27, 23 | Shan Bo | other | 0 |
| Nov 27, 23 | Xu Huibo | other | 0 |
| Nov 27, 23 | Wu Binbin | other | 0 |
| Nov 27, 23 | Li Zhijie | other | 0 |
| Nov 27, 23 | Zhang Liang | other | 0 |
| Nov 27, 23 | Hongxiao Zhou | other | 0 |
| Nov 27, 23 | Liping Kang | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LDDD coverage
Recent articles, reports, and earnings notes.
No research on LDDD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LDDD report →